(Q35684106)

9 August 2017

1 reference

title

Normal-tissue toxicities of thoracic radiation therapy: esophagus, lung, and spinal cord as organs at risk (English)

1 reference

adaptive radiation therapy

9 August 2017

main subject

0 references

author

Timothy E. Schultheiss

object named as

Timothy E Schultheiss

series ordinal

4

0 references

Maria Werner-Wasik

series ordinal

1

object named as

Maria Werner-Wasik

1 reference

9 August 2017

Xiaoli Yu

2

1 reference

9 August 2017

Lawrence B Marks

series ordinal

3

1 reference

9 August 2017

publication date

1 February 2004

1 reference

Hematology / Oncology Clinics of North America

9 August 2017

published in

1 reference

9 August 2017

volume

18

1 reference

9 August 2017

issue

1

1 reference

9 August 2017

page(s)

131-60, x-xi

1 reference

Time-dose relationships in the mouse esophagus

9 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900150-3

7 January 2021

Radiological manifestations of radiation-induced injury to the normal upper gastrointestinal tract

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900150-3

7 January 2021

Radiation-induced injury of the esophagus

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900150-3

7 January 2021

Interruptions of high-dose radiation therapy decrease long-term survival of favorable patients with unresectable non-small cell carcinoma of the lung: analysis of 1244 cases from 3 Radiation Therapy Oncology Group (RTOG) trials

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900150-3

7 January 2021

Endoscopic findings of radiation esophagitis in concurrent chemoradiotherapy for intrathoracic malignancies

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900150-3

7 January 2021

Preliminary report on reduction of esophagitis by amifostine in patients with non-small-cell lung cancer treated with chemoradiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900150-3

7 January 2021

Phase II: trial of twice weekly amifostine in patients with non-small cell lung cancer treated with chemoradiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900150-3

7 January 2021

Exploring the role of the radioprotector amifostine in locally advanced non-small cell lung cancer: Radiation Therapy Oncology Group trial 98-01.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900150-3

7 January 2021

Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900150-3

7 January 2021

Esophagitis induced by combined radiation and adriamycin

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900150-3

7 January 2021

Predictors of severe esophagitis include use of concurrent chemotherapy, but not the length of irradiated esophagus: a multivariate analysis of patients with lung cancer treated with nonoperative therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900150-3

7 January 2021

A phase III study of accelerated radiotherapy with and without carboplatin in nonsmall cell lung cancer: an interim toxicity analysis of the first 100 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900150-3

7 January 2021

Randomised multicentre trials of CHART vs conventional radiotherapy in head and neck and non-small-cell lung cancer: an interim report. CHART Steering Committee

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900150-3

7 January 2021

Response, toxicity, failure patterns, and survival in five Radiation Therapy Oncology Group (RTOG) trials of sequential and/or concurrent chemotherapy and radiotherapy for locally advanced non-small-cell carcinoma of the lung

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900150-3

7 January 2021

Interfraction interval does not affect survival of patients with non-small cell lung cancer treated with chemotherapy and/or hyperfractionated radiotherapy: a multivariate analysis of 1076 RTOG patients

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900150-3

7 January 2021

Esophageal complications from combined chemoradiotherapy (cyclophosphamide + Adriamycin + cisplatin + XRT) in the treatment of non-small cell lung cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900150-3

7 January 2021

Three-Dimensional Conformal Radiation Therapy In Bronchogenic Carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900150-3

7 January 2021

Clinical and dosimetric predictors of radiation-induced esophageal toxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900150-3

7 January 2021

Dosimetric predictors of radiation esophagitis in patients treated for non-small-cell lung cancer with carboplatin/paclitaxel/radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900150-3

7 January 2021

Predictors of radiation-induced esophageal toxicity in patients with non-small-cell lung cancer treated with three-dimensional conformal radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900150-3

7 January 2021

Clinical dose-response curves of human malignant epithelial tumours

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900150-3

7 January 2021

Dose escalation in non-small-cell lung cancer using three-dimensional conformal radiation therapy: update of a phase I trial

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900150-3

7 January 2021

Three-dimensional radiation treatment planning study for patients with carcinoma of the lung.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900150-3

7 January 2021

Optimization of beam weights in conformal radiotherapy planning of stage III non-small cell lung cancer: effects on therapeutic ratio.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900150-3

7 January 2021

Conformal radiotherapy of Stage III non-small cell lung cancer: a class solution involving non-coplanar intensity-modulated beams.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900150-3

7 January 2021

Phase III randomized trial of amifostine as a radioprotector in head and neck cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900150-3

7 January 2021

Protection of acute and late radiation damage of the gastrointestinal tract by WR-2721

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900150-3

7 January 2021

The impact of overall treatment time on the results of radiotherapy for nonsmall cell lung carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900150-3

7 January 2021

Randomized phase III trial of radiation treatment +/- amifostine in patients with advanced-stage lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900150-3

7 January 2021

Placebo-controlled trial of sucralfate for inhibiting radiation-induced esophagitis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900150-3

7 January 2021

Prevention of irradiation-induced esophagitis by plasmid/liposome delivery of the human manganese superoxide dismutase transgene

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900150-3

7 January 2021

Pre-operative chemoradiotherapy in non-small cell lung cancer stage III patients. Feasibility, toxicity and long-term results of a phase II study.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900150-3

7 January 2021

Risk factors for development of radiation pneumonitis following radiation therapy with or without chemotherapy for lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900150-3

7 January 2021

Hyperfractionated accelerated radiation therapy for non-small cell lung cancer: clinical phase I/II trial

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900150-3

7 January 2021

Clinical radiation pneumonitis and radiographic changes after thoracic radiation therapy for lung carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900150-3

7 January 2021

Risk factors of pneumonitis following chemoradiotherapy for lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900150-3

7 January 2021

Accelerated hyperfractionated radiotherapy combined with induction and concomitant chemotherapy for inoperable non-small-cell lung cancer--impact of total treatment time

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900150-3

7 January 2021

Sequential treatment with vindesine–ifosfamide–platinum (VIP) chemotherapy followed by platinum sensitized radiotherapy in stage IIIB non-small cell lung cancer: A phase II trial1Data presented in part at the 61st Annual International Scientific

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900150-3

7 January 2021

Risk factors for severe radiation pneumonitis in lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900150-3

7 January 2021

Clinical dose-volume histogram analysis for pneumonitis after 3D treatment for non-small cell lung cancer (NSCLC)

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900150-3

7 January 2021

Factors predicting severe radiation pneumonitis in patients receiving definitive chemoradiation for lung cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900150-3

7 January 2021

Prospective evaluation of early lung toxicity following three-dimensional conformal radiation therapy in non-small-cell lung cancer: preliminary results

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900150-3

7 January 2021

Radiation pneumonitis in lung cancer patients: a retrospective study of risk factors and the long-term prognosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900150-3

7 January 2021

Radiation-induced pulmonary toxicity: a dose-volume histogram analysis in 201 patients with lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900150-3

7 January 2021

Estimation of pneumonitis risk in three-dimensional treatment planning using dose-volume histogram analysis.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900150-3

7 January 2021

Chemotherapy with or without radiation therapy in limited small-cell carcinoma of the lung

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900150-3

7 January 2021

Pulmonary Effects of Radiation Therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900150-3

7 January 2021

Palliative radiotherapy for inoperable carcinoma of the lung: final report of a RTOG multi-institutional trial

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900150-3

7 January 2021

Effect of pentoxifylline on radiation response of non-small cell lung cancer: a phase III randomized multicenter trial

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900150-3

7 January 2021

A prospective randomized study of various irradiation doses and fractionation schedules in the treatment of inoperable non-oat-cell carcinoma of the lung. Preliminary report by the Radiation Therapy Oncology Group

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900150-3

7 January 2021

Dose-volume histogram and 3-D treatment planning evaluation of patients with pneumonitis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900150-3

7 January 2021

Effect of postoperative radiotherapy on changes in pulmonary function in patients with stage II and IIIA lung carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900150-3

7 January 2021

THE EFFECTS OF RADIATION THERAPY ON PULMONARY FUNCTION IN CARCINOMA OF THE LUNG

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900150-3

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900150-3

7 January 2021

Regional dose response to pulmonary irradiation using a manual method

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900150-3

7 January 2021

Radiation and the lung: a reevaluation of the mechanisms mediating pulmonary injury

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900150-3

7 January 2021

Radiation-induced and chemotherapy-induced pulmonary injury

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900150-3

7 January 2021

The effect of patient-specific factors on radiation-induced regional lung injury.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900150-3

7 January 2021

73.6 Gy and beyond: hyperfractionated, accelerated radiotherapy for non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900150-3

7 January 2021

Bronchial stenosis and sclerosing mediastinitis: an uncommon complication of external thoracic radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900150-3

7 January 2021

Effect of cancer chemotherapeutic drugs on radiation-induced lung damage in mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900150-3

7 January 2021

Radiation Therapy Oncology Group (RTOG) 88-08 and Eastern Cooperative Oncology Group (ECOG) 4588: preliminary results of a phase III trial in regionally advanced, unresectable non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900150-3

7 January 2021

Radiosensitization with carboplatin for patients with unresectable stage III non-small-cell lung cancer: a phase III trial of the Cancer and Leukemia Group B and the Eastern Cooperative Oncology Group

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900150-3

7 January 2021

Effects of Concomitant Cisplatin and Radiotherapy on Inoperable Non-Small-Cell Lung Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900150-3

7 January 2021

Radiation pneumonitis and fibrosis following split-course radiation therapy for lung cancer. A radiologic and physiologic study

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900150-3

7 January 2021

Prospective prediction of post-radiation therapy lung function using quantitative lung scans and pulmonary function testing

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900150-3

7 January 2021

Effects of proton and combined proton/photon beam radiation on pulmonary function in patients with resectable but medically inoperable non-small cell lung cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900150-3

7 January 2021

Correlation between lung fibrosis and radiation therapy dose after concurrent radiation therapy and chemotherapy for limited small cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900150-3

7 January 2021

Radiation-induced lung fibrosis after treatment of small cell carcinoma of the lung with very high-dose cyclophosphamide

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900150-3

7 January 2021

The time course of radiation therapy-induced reductions in regional perfusion: a prospective study with >5 years of follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900150-3

7 January 2021

Radiation dose-effect relations and local recovery in perfusion for patients with non-small-cell lung cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900150-3

7 January 2021

Dose-volume factors contributing to the incidence of radiation pneumonitis in non-small-cell lung cancer patients treated with three-dimensional conformal radiation therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900150-3

7 January 2021

Receiver operating characteristic curves to assess predictors of radiation-induced symptomatic lung injury

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900150-3

7 January 2021

Plasma transforming growth factor beta1 as a predictor of radiation pneumonitis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900150-3

7 January 2021

Radiation pneumonitis and early circulatory cytokine markers.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900150-3

7 January 2021

Survival in radiation myelopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900150-3

7 January 2021

Dose Effect Relationships in Cervical and Thoracic Radiation Myelopathies

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900150-3

7 January 2021

The latent period in clinical radiation myelopathy.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900150-3

7 January 2021

Episodic neurologic dysfunction in patients with Hodgkin's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900150-3

7 January 2021

Radiation myelitis: can diagnosis be unequivocal without histological evidence?

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900150-3

7 January 2021

Radiation Myelitis Simulating Tumor

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900150-3

7 January 2021

Diffuse cord enlargement in radiation myelopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900150-3

7 January 2021

Electrophysiologic evidence of subclinical injury to the posterior columns of the human spinal cord after therapeutic radiation

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900150-3

7 January 2021

Motor conduction velocity in the human spinal cord: slowed conduction in multiple sclerosis and radiation myelopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900150-3

7 January 2021

Time- and dose-related changes in the white matter of the rat brain after single doses of X rays

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900150-3

7 January 2021

Development of blood vessel-related radiation damage in the fimbria of the central nervous system

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900150-3

7 January 2021

Changes in the neuroglial cell populations of the rat spinal cord after local X-irradiation

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900150-3

7 January 2021

Tissue Tolerance: Central Nervous System

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900150-3

7 January 2021

Neurologic complications after irradiation of the cervical spinal cord for malignant tumour of the head and neck

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900150-3

7 January 2021

Radiation tolerance of the cervical spinal cord

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900150-3

7 January 2021

Increased Rate of Complications as a Result of Treating Only One Prescribed Field Daily

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900150-3

7 January 2021

Radiation response of the central nervous system

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900150-3

7 January 2021

Radiation myelopathy in primates treated with conventional fractionation

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900150-3

7 January 2021

The radiosensitivity of the guinea-pig spinal cord to X-rays: the effect of retreatment at one year and the effect of age at the time of irradiation.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900150-3

7 January 2021

Continuous, hyperfractionated, accelerated radiotherapy (CHART): an interim report upon late morbidity

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900150-3

7 January 2021

Myelopathy following hyperfractionated accelerated radiotherapy for anaplastic thyroid carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900150-3

7 January 2021

Repair kinetics in tissues: alternative models

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900150-3

7 January 2021

The incidence of myelitis after irradiation of the cervical spinal cord

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900150-3

7 January 2021

The effect of small radiation doses on the rat spinal cord: the concept of partial tolerance

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900150-3

7 January 2021

Isoeffect curve for radiation myelopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900150-3

7 January 2021

Dose effect relationship for epilation and late effects on spinal cord in rats exposed to gamma rays

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900150-3

7 January 2021

Radiation tolerance of the rat spinal cord: time-dose relationships

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900150-3

7 January 2021

Linear-quadratic model underestimates sparing effect of small doses per fraction in rat spinal cord

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900150-3

7 January 2021

Late effects of 50 MeV d leads to Be neutron and cobalt-60 irradiation of rhesus monkey cervical spinal cord

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900150-3

7 January 2021

Volume effects in rhesus monkey spinal cord

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900150-3

7 January 2021

Probable causes of recurrence in patients with chordoma and chondrosarcoma of the base of skull and cervical spine.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900150-3

7 January 2021

Extent and kinetics of recovery of occult spinal cord injury

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900150-3

7 January 2021

Radiation myelopathy in relation to oxygen level

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900150-3

7 January 2021

Radiosensitivity of the human oxygenated cervical spinal cord based on analysis of 357 cases receiving 4 MeV x rays in hyperbaric oxygen

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900150-3

7 January 2021

Hemoglobin, radiation, morbidity and survival

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900150-3

7 January 2021

The nature of latent cerebral irradiation damage and its modification by hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900150-3

7 January 2021

10.1016/S0889-8588(03)00150-3

Identifiers

DOI

1 reference

9 August 2017

1 reference